Effect of apolipoprotein E allele ε4 on the initial phase of amyloid β-protein accumulation in the human brain

American Journal of Pathology

Volumn 157, Issue 6, 2000, Pages 2093-2099

  Morishima Kawashima, Maho ^a   Oshima, Noriko ^a,b   Ogata, Hiromitsu ^c   Yamaguchi, Haruyasu ^d   Yoshimura, Masahiro ^e   Sugihara, Shiro ^f   Ihara, Yasuo ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^d GUNMA UNIVERSITY   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f Gunma Cancer Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ADULT; AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN TISSUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACTION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033635302     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64847-X     Document Type: Article

References (38)

1. Human apolipoprotein E: The Alzheimer's disease connection
2. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
3. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
4. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
5. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
6. Quantitation of amyloid β-protein (Aβ) in the cortex during aging and in Alzheimer's disease
7. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
8. Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease
9. Preferential deposition of amyloid β protein (Aβ) in the form Aβ40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele
10. Aβ1-40 but not Aβ1-42 levels in cortex correlate with apolipoprotein E ε4 allele dosage in sporadic Alzheimer's disease
11. A high incidence of apolipoprotein E ε4 allele in middle-aged non-demented subjects with cerebral amyloid β protein deposits
12. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions
13. Apolipoprotein E4 promotes the early deposition of Aβ42 and then Aβ40 in the elderly
14. The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: Clinicopathological study of 57 cases
15. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
16. An increased percentage of long amyloid β-protein secreted by familial amyloid β-protein precursor (βAPP717) mutants
17. Long amyloid β-protein secreted from wild-type human neuroblastoma IMR-32 cells
18. Amyloid β-protein deposition in the leptomeninges and cerebral cortex
19. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease
20. The presence of amyloid β-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells
21. Appearance of sodium dodecyl sulfate-stable amyloid β-protein (Aβ) dimer in the cortex during aging
22. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal
23. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease
24. Dose-dependent association of apolipoprotein E allele ε4 with late-onset, sporadic Alzheimer's disease
25. Modified amyloid β protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease
26. Heterogeneity of water-soluble amyloid β-peptide in Alzheimer's disease and Down's syndrome brains
27. ApoE-ε4 and early-onset Alzheimer's
28. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution
29. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
30. Functional rafts in cell membranes
31. A detergent-insoluble membrane compartment contains Aβ in vivo
32. Intraneuronal Aβ42 accumulation in human brain
33. Aβ42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease
34. Deposition of β/A4 protein along neuronal plasma membranes in diffuse senile plaques
35. The genesis of the senile plaque. Further evidence in support of its neuronal origin
36. Amyloid β protein (Aβ) starts to deposit as plasma membrane-bound form in diffuse plaques of brains from hereditary cerebral hemorrhage with amyloidosis-Dutch type, Alzheimer disease and nondemented aged subjects
37. Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice
38. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons